All Stories

  1. The cerebellum beyond motor control: cognitive dysfunction in spinocerebellar ataxias
  2. Gilles de La Tourette syndrome: the contribution of Guinon
  3. The cerebellar involvement in essential tremor: the connecting roads
  4. Cognitive Changes in Pre‐ataxic Spinocerebellar Ataxias: A Scoping Review
  5. Alix Joffroy (1844–1908)
  6. Spinocerebellar Ataxia Type 10 (SCA 10) in Brazil
  7. How great was the influence of his origins and descendants on Charcot's behaviors?
  8. Arquivos de Neuro-Psiquiatria: 82 years old, a new phase begins now
  9. Charcot's Russian pupils
  10. Fulgence Raymond: from rural life and veterinary medicine to Charcot's successor at La Salpêtrière Hospital
  11. A hiatus in the rivalry between Pierre Marie and Jules Dejerine: a collaborative study on sensory disorders by Andre Pierre Marie and Gustave Roussy
  12. The prominent role of Charcot and the French neurological tradition in Latin America
  13. François Rabelais and his dystonic giants
  14. The Huntington's Disease Gene Discovery
  15. Static posturography analysis for postural instability in patients with Parkinson’s disease
  16. Imbalance and gait impairment in Parkinson’s disease: discussing postural instability and ataxia
  17. Jean-Martin Charcot: the polymath
  18. Autosomal Recessive Cerebellar Ataxias: New Acronyms, Old Eponyms, and the Butterfly Life Cycle
  19. Chronic Pain And Levodopa Therapy in Parkinson’s Disease Patients
  20. The expulsion of Augusta Dejerine-Klumpke from the Salpêtrière Hospital: Pierre Marie's revenge
  21. The importance of the Brazilian Society of Neurological Investigation (SBIN)
  22. Thomas Willis' legacy on the 400th anniversary of his birth
  23. Inherited metabolic diseases mimicking hereditary spastic paraplegia (HSP): a chance for treatment
  24. Ramsay Hunt syndrome: New impressions in the era of molecular genetics
  25. “I’m gonna lose my strength, I’m gonna seize and die, And all that Jazz”! Neurological diseases in jazz legends
  26. Functionality and disease severity in spinocerebellar ataxias
  27. Evaluation of Brain SPECT with 99mTc‐TRODAT‐1 in the Differential Diagnosis of Parkinsonism
  28. Reply to: “Cognitive Impairments in Spinocerebellar Ataxia Type 10 and Their Relation to Cortical Thickness”
  29. Constantin von Economo´s 90th death anniversary
  30. Would Charcot’s “hystero-epilepsy” be a hypofunction of the NMDA receptors?
  31. Treatment of occipital neuralgia using onabotulinum toxin A
  32. Would Francisco Soca have been the first to relate toe phenomenon as pyramidal disorders?
  33. Spinocerebellar ataxia type 21 (TMEM240) with tremor and dystonia
  34. Patients with Cervical Dystonia Demonstrated Decreased Cognitive Abilities and Visual Planning Compared to Controls
  35. Freezing of gait (FOG) in Parkinson’s disease patients—the contribution of Garcin and Melaragno
  36. Reply
  37. It Is Time to Define Huntington's Disease Onset more Clearly
  38. Autosomal‐Recessive Cerebellar Ataxias and Movement Disorders With Elevated Alpha‐Fetoprotein
  39. Charcot: Buddhist Leanings?
  40. Nobel and Charcot in Paris: A Brazilian Connection?
  41. The Art of Charcot: An Outstanding Caricaturist
  42. Balance and physical functioning in Spinocerebellar ataxias 3 and 10
  43. Is Ataxia an Underestimated Symptom of Huntington's Disease?
  44. Follow-Up of Advanced Parkinson’s Disease Patients after Clinical or Surgical Emergencies: A Practical Approach
  45. The Role of the Cerebellum in Huntington’s Disease: a Systematic Review
  46. Upward Gaze Palsy: a Valuable Sign to Distinguish Spinocerebellar Ataxias
  47. Volumetric MRI Changes in Spinocerebellar Ataxia (SCA3 and SCA10) Patients
  48. Tribute to Professor Andrew J. Lees
  49. Comment on: “Investigation of intermediate CAG alleles of the HTT in the general population of Rio de Janeiro, Brazil, in comparison with a sample of Huntington disease‐affected families.”
  50. Neurology, psychiatry and the chess game: a narrative review
  51. Reply to Comment on: The Geographic Diversity of Spinocerebellar Ataxias (SCAs) in the Americas
  52. Assessment of ventilatory function in patients with spinocerebellar ataxia type 2
  53. Blepharospasm and periorbital edema after imatinib mesylate: improvement with botulinum toxin
  54. Charcot and His Passion for Dogs: A Historical Note
  55. Is fatigue an important finding in patients with spinocerebellar ataxia type 10 (SCA10)?
  56. The Duels of Pierre Marie and Jules Dejerine
  57. Reply to Comment on: The geographic diversity of spinocerebellar ataxias (SCAs) in the Americas: A systematic review
  58. Overcoming bashfulness: how cocaine aided Freud to summon the courage to meet Charcot
  59. Spinocerebellar ataxias in Southern Brazil: Genotypic and phenotypic evaluation of 213 families
  60. Nonmotor symptoms in spinocerebellar ataxias (SCAs)
  61. The Geographic Diversity of Spinocerebellar Ataxias (SCAs) in the Americas: A Systematic Review
  62. Charcot's paradox
  63. Sporadic adult-onset spinocerebellar ataxias
  64. Hyposkillia and spanophilia in the movement disorders rounds
  65. Reply to: Early distinction of Parkinson variant multiple system atrophy from Parkinson's disease
  66. The Legacy of Charles David Marsden: A Role Model in the Field of Movement Disorders
  67. The Melted Statue of Charcot: The Nazi Occupation of Paris During World War II
  68. The Effectiveness of Reality Orientation Therapy in the Treatment of Parkinson Disease Dementia
  69. Association between olfactory loss and cognitive deficits in Parkinson's disease
  70. Abnormal Findings in Polysomnographic Recordings of Patients with Spinocerebellar Ataxia Type 2 (SCA2)
  71. Édouard Brissaud: distinguished neurologist and Charcot’s pupil
  72. Yawning in neurology: a review
  73. “ Flâneur neurologique in paris” – A guide to pinpointing the houses of famous neurologists in the late XIX century
  74. Antisense Oligonucleotide Therapy for Spinocerebellar Ataxias: Good News for Terrible Diseases
  75. Sleep disorders in spinocerebellar ataxia type 10
  76. When multiple sclerosis and X-linked adrenoleukodystrophy are tangled
  77. Can the CERAD neuropsychological battery be used to assess cognitive impairment in Parkinson's disease?
  78. Broken dynasty: how Jean Batiste Charcot relinquished his father’s neurological empire to conquer the seven seas
  79. More than ataxia – Movement disorders in ataxia-telangiectasia
  80. Searching for neurological diseases in the Julio-Claudian dynasty of the Roman Empire
  81. Different Cerebellar Ataxia Phenotypes Associated with Mutations of the PNPLA6 Gene in Brazilian Patients with Recessive Ataxias
  82. Apathy and depression in Parkinson Disease Dementia
  83. Attention deficit hyperactivity disorder and drug addiction rehabilitation patients
  84. Neurophysiological and neuroimaging changes (crossed cerebrocerebellar atrophy) after prolonged non-convulsive status epilepticus
  85. Classification and Characteristics of Pain Associated with Parkinson’s Disease
  86. Tourette's syndrome in famous musicians
  87. Cerad battery can be used for the diagnosis of dementia in Parkinson's disease?
  88. Pain assessment in wearing off period of levodopa treatment for Parkinson’s disease
  89. Dysphagia in Dystonia
  90. Dysphagia in Parkinson’s Disease
  91. Pain Relief in Cervical Dystonia with Botulinum Toxin Treatment
  92. The genetics of the dystonias – a review based on the new classification of the dystonias
  93. The Effectiveness of Reality Orientation in the Treatment of Alzheimer’s Disease
  94. Abnormal Cerebrovascular Reactivity in Patients with Parkinson’s Disease
  95. Genetic evaluation for TOR1-A (DYT1) in Brazilian patients with dystonia
  96. Evolution of the concept of dystonia
  97. Cervical dystonia: about familial and sporadic cases in 88 patients
  98. Cervical dystonia: clinical and therapeutic features in 85 patients
  99. Movement disorders secondary to long-term treatment with cyclosporine A
  100. Frequency of obsessive and compulsive symptoms in patients with blepharospasm and hemifacial spasm
  101. Frequency of obsessive and compulsive symptoms in patients with blepharospasm and hemifacial spasm
  102. Uso do propranolol de ação prolongada em 40 pacientes com tremor essencial e virgens de tratamento: um ensaio clínico não controlado
  103. Myotonia congenita and myoadenylate deaminase deficiency: case report
  104. Hemimasticatory spasm treated with botulinum toxin: case report
  105. Machado-Joseph disease versus hereditary spastic paraplegia: case report
  106. Hereditary spastic paraplegia associated with thin corpus callosum
  107. Reversible posterior leucoencephalopathy syndrome associated with bone marrow transplantation
  108. Acidente vascular cerebral em pacientes jovens: análise de 164 casos
  109. Alpha-Synucleinopathies
  110. Neurosurgical Treatments of Neurodegenerative Disorders
  111. Stroke